Last reviewed · How we verify
NCT06281522: Echinococcusis
The Importance of Inflammatory Markers Calculated From Preoperative and Postoperative Peripheral Blood Results in the Diagnosis and Treatment of Patients Operated for Hydatid Cyst of the Lung (Lung Echinococcus Granulosus)
trial testing Operated patients with hydatid cyst of the lung in Lung Hydatid Cyst in 54 participants. Status unknown.
30 March 2024
Quick facts
| Lead sponsor | Abdullah Adiyaman |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 54 |
| Start date | 18 December 2023 |
| Primary completion | 30 March 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Operated patients with hydatid cyst of the lung
Conditions studied
- Lung Hydatid Cyst — all drugs for Lung Hydatid Cyst →
Sponsor
Abdullah Adiyaman
Who can join
Adults 18 to 83, any sex, with Lung Hydatid Cyst. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the role of these laboratory findings in the differential diagnosis and management of pulmonary hydatid cyst (PHC) by examining the number of euzonophils, neutrophils, lymphocytes, platelets and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune inflammatory index values in the peripheral blood of patients diagnosed with pulmonary hydatid cyst (PHC) in the preoperative period and post-operative 3rd month. Although we have extensive data on hydatid liver cysts, there is limited information in the literature on the laboratory values of patients with PHC. This study aims to provide more scientific basis for the diagnosis and management of PHC and is considered as an inexpensive, reproducible and easily calculable method to improve the accurate diagnosis and management of AKH in clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06281522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06281522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abdullah Adiyaman
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06281522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing